First new drug for Alzheimer's in 20 years approved by FDA
0:33
CBS News
First new drug for Alzheimer's in 20 years approved by FDA
The Food and Drug Administration has granted approval to a drug called Aduhelm, developed by Biogen, for patients with Alzheimer's disease. The decision comes despite warnings from independent advisers that there isn't strong enough evidence to prove the treatment is effective in slowing the disease. Read more here .
Jun 7, 2021
Related Products
Biogen Aduhelm FDA Label Carton
Aduhelm
Aduhelm Abeta
#What Is Aducanumab
Leading Canadian researchers say Alzheimer’s drug aducanumab should not be approved in Canada, at least not yet — despite being approved by the U.S. FDA. Reporting by Christine Birak | CBC News: The National
Leading Canadian researchers say Alzheimer’s drug aducanumab should not be approved in Canada, at least not yet — despite being approved by the U.S. FDA. Reporting by Christine Birak | CBC News: The National
FacebookAug 13, 2021
In controversial decision, FDA approves first new Alzheimer's disease drug in nearly 20 years
In controversial decision, FDA approves first new Alzheimer's disease drug in nearly 20 years
ABC7 New YorkJun 7, 2021
Top videos
Biogen Investigates Death of Aduhelm Patient
Biogen Investigates Death of Aduhelm Patient
wsj.com
1 month ago
Aduhelm Biogen Jadi Obat Pertama yang Targetkan Penyebab Alzheimer - Tribunnews.com
Aduhelm Biogen Jadi Obat Pertama yang Targetkan Penyebab Alzheimer - Tribunnews.com
tribunnews.com
Jul 10, 2021
FDA and Biogen's push to accelerate approval of Alzheimer's drug
5:00
FDA and Biogen's push to accelerate approval of Alzheimer's drug
CBS News
Jul 2, 2021
Aducanumab Alzheimers Treatment
The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug | WSJ
6:10
The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug | WSJ
YouTubeThe Wall Street Journal
120.9K viewsMar 29, 2022
Can Alzheimer's Disease Be Reversed with a Plant Based Diet?
8:42
Can Alzheimer's Disease Be Reversed with a Plant Based Diet?
YouTubeNutritionFacts.org
172.9K viewsJun 7, 2024
Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab
5:54
Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab
YouTubeNutritionFacts.org
21.1K viewsOct 23, 2023
Biogen Investigates Death of Aduhelm Patient
Biogen Investigates Death of Aduhelm Patient
1 month ago
wsj.com
Aduhelm Biogen Jadi Obat Pertama yang Targetkan Penyebab Alzheimer - Tribunnews.com
Aduhelm Biogen Jadi Obat Pertama yang Targetkan Penyebab Alzhei…
Jul 10, 2021
tribunnews.com
FDA and Biogen's push to accelerate approval of Alzheimer's drug
5:00
FDA and Biogen's push to accelerate approval of Alzheimer'…
Jul 2, 2021
CBS News
Biogen interrompt le développement de l'Aduhelm, son ancien médicament contre la maladie d'Alzheimer
Biogen interrompt le développement de l'Aduhelm, son ancien médica…
Jan 31, 2024
zonebourse.com
Biogen: ADUHELM Continues To Reduce Underlying Pathologies Of Alzheimer's Beyond Two Years
Biogen: ADUHELM Continues To Reduce Underlying Pathologies O…
Mar 16, 2022
nasdaq.com
Change at the top for Biogen after Alzheimer's drug flops
Change at the top for Biogen after Alzheimer's drug flops
1 month ago
kvia.com
Aleph News
1:54
Aleph News
Jun 12, 2021
alephnews.ro
$
Medicare ordered to reassess premium hike for Alzheimer’s drug
Jan 10, 2022
FortuneRicardo Alonso-Zaldivar,The Associated Press
Biogen discontinues Alzheimer’s medication Aduhelm - Local News 8
Jan 31, 2024
localnews8.com
Aduhelm (aducanumab) Q A - Penn Memory Center
Feb 1, 2023
pennmemorycenter.org
$
FDA approves Biogen’s controversial Alzheimer’s drug in …
Jun 7, 2021
FortuneSy Mukherjee
Biogen Cuts Price for Alzheimer’s Drug Aduhelm by Half
Dec 20, 2021
wsj.com
Could Advocacy Groups' Campaign for Aduhelm Benefit Biogen? | Th…
Feb 19, 2022
fool.com
Biogen plans to shut down its controversial Alzheimer’s drug Ad…
Jan 31, 2024
torontosunAssociated Press,Tom Murphy
Biogen tumbles after Medicare lays out Aduhelm coverage plan
Jan 12, 2022
seattletimes.com
0:51
At Biogen, our commitment goes beyond research—it’s about maki…
288 views1 year ago
FacebookBiogen
Mass.-based Biogen will shut down its controversial Alzheimer's drug …
Jan 31, 2024
WCVBThe Associated Press
6:35
FDA Gives Green Light to Biogen's Alzheimer???s Drug - 6/7/2021
Jun 7, 2021
Bloomberg.com
Aducanumab (Aduhelm) For Alzheimer’s Disease » Departmen…
Jul 1, 2021
ufl.edu
Aduhelm, Biogen’s Alzheimer’s drug, stirs hope for patients, worr…
Jun 27, 2021
masslive.com
0:18
19 reactions | As the number of adults living with Alzheimer’s and …
2K views2 weeks ago
FacebookBiogen
0:08
34 reactions | Did you know there are over 100 forms of dementia an…
311 views3 weeks ago
FacebookBiogen
2:28
73 reactions · 13 shares | For more than 100 years scientists have...
26.4K views2 weeks ago
FacebookBiogen
$
Inside the lobbying push to get Medicare to pay for a controversia…
Feb 16, 2022
FortuneArthur Allen,Kaiser Health News
1:31
Biogen CEO to step down after Alzheimer's drug snags
11.5K viewsMay 3, 2022
YahooReuters Videos
1:16
FDA narrows label for Biogen’s Alzheimer’s drug
31.1K viewsJul 8, 2021
YahooReuters Videos
1:28
Biogen cuts the price tag on its Alzheimer's drug in half
288.9K viewsDec 20, 2021
YahooYahoo News Video
1:32
U.S. approval of Biogen Alzheimer's drug sends shares soaring, haile…
Jun 7, 2021
ReutersJulie Steenhuysen,Deena Beasley
6:10
Alzheimer’s Patients Now Less Likely to Receive Biogen’s Aduhel…
May 3, 2022
WSJPeter Loftus
See more videos
Static thumbnail place holder